Meeting
2017 ASCO Annual Meeting
Prospective study of magnetic resonance imaging (MRI) and multiparameter gene expression assay in ductal carcinoma in situ (DCIS): A trial of the ECOG-ACRIN cancer research group (E4112).
Authors
Seema Ahsan Khan
Northwestern Memorial Hospital, Chicago, IL
Seema Ahsan Khan , Constantine Gatsonis , Brad Snyder , Constance D Lehman , Joseph A. Sparano , Lawrence J. Solin , Sunil S. Badve , Ralph L Corsetti , Habib Rahbar , Derrick W Spell , Kenneth Bruce Blankstein , LInda K Han , Jennifer L. Sabol , John R Bumberry , Kathy D. Miller , Christopher Comstock
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Breast Cancer—Local/Regional/Adjuvant
Track
Breast Cancer
Sub Track
Adjuvant Therapy
Clinical Trial Registration Number
E4112
Citation
J Clin Oncol 35, 2017 (suppl; abstr 534)
DOI
10.1200/JCO.2017.35.15_suppl.534
Abstract #
534
Poster Bd #
134
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Quality Care Symposium
Endocrine therapy initiation among women diagnosed with ductal carcinoma in situ breast cancer from 2001-2016.
First Author: Erin Aiello Bowles
Poster
2022 ASCO Annual Meeting
Mode of detection of second breast cancers in patients undergoing surveillance after treatment of ductal carcinoma in situ.
First Author: Bethany Waites
Poster
2020 ASCO Virtual Scientific Program
Ipsilateral invasive cancer risk after diagnosis with ductal carcinoma in situ (DCIS): Comparison of patients with and without index surgery.
First Author: Marc D Ryser
Poster
2015 Breast Cancer Symposium
Preoperative breast MRI and MR-guided surgery of invasive breast cancers with and without DCIS components.
First Author: Christiane K. Kuhl